FIGURE
Fig. 4
- ID
- ZDB-FIG-181207-57
- Publication
- Jin et al., 2018 - Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograft zebrafish model
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 4
Gross morphological changes in the zebrafish larvae following anti-angiogenic compound exposure at 120 hpf. Wild-type zebrafish were collected at 6 hpf and were treated with bevacizumab (28 ng, 83 ng and 250 ng per embryo), endostar (11 ng, 33 ng and 99 ng per embryo) and apatinib (0.22 μg/mL, 0.67 μg/mL and 2 μg/mL dissolved in breeding water) at 28 °C until 120 hpf. Apatinib (0.67 µg/mL) treatment: pericardial edema (arrow); apatinib (2 µg/mL) treatment: pericardial edema (arrow), decreased eye size (arrowhead) and shortened body axis. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Sci. Rep.